The human LT system. VII. Release of soluble forms and delivery to target L-929 cells by lectin-preactivated human lymphocytes in the absence of protein synthesis and secretory processes.
D000818:Animals; D003078:Colchicine / Q000494:pharmacology; D003513:Cycloheximide / Q000494:pharmacology; D003571:Cytochalasin B / Q000494:pharmacology; D003602:Cytotoxicity, Immunologic; D004640:Emetine / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D007739:L Cells / Q000276:immunology; D037102:Lectins / Q000494:pharmacology*; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology*; D008233:Lymphotoxin-alpha / Q000378:metabolism*; D051379:Mice; D014176:Protein Biosynthesis; D011506:Proteins / Q000378:metabolism
D037102:Lectins; D008233:Lymphotoxin-alpha; D011506:Proteins; D003571:Cytochalasin B; D003513:Cycloheximide; D003078:Colchicine; D004640:Emetine